Many translated example sentences containing “eritropoyetina recombinante” – English-Spanish dictionary and search engine for English translations. La farmacocinética de la eritropoyetina recombinante humana en pacientes con nefropatía endémica de los Balcanes. The Pharmacokinetics of Recombinant. Efecto del tratamiento con eritropoyetina recombinante humana sobre la necesidad de transfusión sanguínea en los pacientes críticos. Effect of human.
|Published (Last):||5 February 2012|
|PDF File Size:||2.28 Mb|
|ePub File Size:||3.12 Mb|
|Price:||Free* [*Free Regsitration Required]|
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. Population pharmacokinetics of darbepoetin alfa in healthy subjects. The main limitation of our study was the small number of patients in each group, and they were not matched in age.
Eritropoyetina recombinante humana en la insuficiencia renal crónica
However, the influence of ESA pharmacokinetics on hematopoietic response has not been sufficiently investigated. The enigma of the metabolic fate of circulating erythropoietin Epo in view of the pharmacokinetics of the recombinant drugs rhEpo and NESP. Predialysis serum creatinine and PTH concentrations were significantly lower, and serum calcium concentration was significantly higher in the BEN than in the non-BEN group.
Previous article Next article. Nephrol Dial Transplant ;19 Suppl 2: Eritfopoyetina analyze briefly the clinical indications of rHuEpo and the possible complications secondary to its use.
There was a problem providing the content you requested
Serum levels of iron, ferritin, transferrin saturation, C-reactive protein CRPalbumin, urea, creatinine, calcium, phosphorus and parathyroid hormone PTH were determined in each patient at the time of study. As previous studies showed that the kidneys contribute to Epo elimination in a very minor fashion 35 and residual kidney function in patients more than three years on dialysis is most often negligible, it is not expected that renal elimination of Epo could be of any influence.
Subscribe to free Drugs.
However, for protein and peptide drugs, dependency on active tissue uptake, binding to intra- and extravascular proteins can substantially increase the value eritropoyteina Vd. This item has received. This finding needs to be confirmed in a well-controlled study with a larger sample size. Continuing navigation will be considered as acceptance of this use.
CiteScore measures average citations received per document published. Pavlovic-Kentera V, Djukanovic Lj. Subscribe to our Newsletter. The Ethics Committee of the Clinical Center of Serbia evaluated and approved the study and the participants gave informed consent.
The results were expressed as mean values with standard deviations. Si continua navegando, consideramos que acepta eritropoyetima uso.
Endemic nephropathy in Yugoslavia. SRJ is a prestige metric based on the idea that not all citations are the same. Si continua navegando, consideramos que acepta su uso. The dose of beta-Epo was adjusted to attain the hemoglobin target range defined by European best practice guidelines for the management of anemia in patients with chronic renal failure The utilization of rHuEp changed definitively the treatment and the natural history of anemia in patients with chronic renal insufficiency CRIand now is modifying the treatment of anemia of other non-renal patients as anemia of premature, anemia in onco-hematological illnesses, anemia in human immunodeficiency virus HIV infection, and for reduction of allogenic blood transfusions in surgery.
Endemic Balkan Nephropathy, Recomhinante. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.
Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production.
Higher dose of erythropoietin for anemia correction in Balkan tecombinante nephropathy patients. Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist ERA in healthy volunteers.
Renal Injury from Drugs and Chemicals, third edition. July Pages Endemic nephropathy in Bosnia.
Eritropoyetina Humana Recombinante Delta –
The journal accepts submissions of articles in English and in Spanish languages. Conflicts of interest The authors declare that they have no conflicts of interest related to the contents of this article.
Print Send to a friend Export reference Mendeley Statistics. Show all Show less. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years. Pharmacokinetic analysis of beta-erythropoietin detected a significantly longer elimination half-life in BEN than in non BEN patients.
European best practice guidelines working group: Res Commun Mol Pathol Pharmacol ; Srp arh cel lek ; Their main characteristics are presented in Table 1. The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Si continua navegando, consideramos que acepta su uso.
Basal plasma Epo concentration in BEN patients ranged between 7. Show all Show less. Delayed massive cerebral fat embolism secondary to severe polytrauma. SJR uses a similar algorithm as eritropogetina Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. Inflammation and its impact on anaemia in chronic kidney disease: